RSS

DSS Document Security Systems

Last Post: 07/31/23
Followers: 10
Posts Today: 0
Views Today: 1642

DSS Stock Quote & Tools

$0.5440 ▲ +0.0000 (+0.00%) As of Aug 28, 4:00 PM EDT
Last0.5440
$ Chg0.0000
Open0.5420
High0.5440
Beta0.9661
Year High1.860
Market Cap5.46M
P/B Ratio-14.30
EPS-2.95
Avg Vol (30d)32.1K
Volume1.5K
% Chg+0.00%
Prev Close0.5440
Low0.5420
VWAP0.54224
Year Low0.361
Total Shares10.04M
Shares Out10.04M
Float3.90M
ExchangeNYSE American
Consumer Discretionary Containers & Packaging

DSS Stock Message Board Discussion

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Explore Rights in Symbotic Class Action

Updated Category News Views 77

Understanding the Class Action Lawsuit for Symbotic Inc. Investors in Symbotic Inc. (NASDAQ:SYM) are currently facing significant concerns regarding recent developments within the company. A class action lawsuit has been initiated in the U.S. District Court for the District of Massachusetts, aimed at those investors who purchased securities between the specified dates....

Continue Reading
Egypt's President Sisi Reflects on IMF Agreement Amid Crisis

Updated Category News Views 169

Egypt's Economic Landscape Under Scrutiny In light of unprecedented regional challenges, Egyptian President Abdel Fattah al-Sisi has raised concerns regarding the nation's ongoing agreement with the International Monetary Fund (IMF). The $8 billion financial support program, signed amidst economic turbulence, may be revisited if the expectations of global financial...

Continue Reading
Insights into Mastercard's Recent Options Trading Dynamics

Updated Category News Views 102

Mastercard's Options Activity: What's Happening? Recently, the options market has seen significant movement from large investors, commonly referred to as "whales." This activity indicates a largely bearish sentiment towards Mastercard. In our analysis of the recent trades involving Mastercard MA, we identified eight significant transactions. Interestingly, none of these...

Continue Reading
Coave Therapeutics Raises Significant Funding for Genetic Breakthroughs

Updated Category News Views 292

Coave Therapeutics Secures Major Investment to Propel Innovation Coave Therapeutics, a pioneer in the realm of genetic medicines, has successfully raised €32 million (approximately $33 million) in a Series A financing round. This funding was notably co-led by Novo Holdings A/S and Bpifrance, with additional contributions from leading investors in the US and EU,...

Continue Reading
Strive Expands with MSTR True North Acquisition and Leadership Change

Updated Category News Views 140

Strive's Exciting Acquisition of MSTR True North Inc. Strive, Inc. has made waves in the financial technology sector with its strategic acquisition of MSTR True North Inc. This move marks a pivotal moment in Strive's journey, enhancing its commitment to Bitcoin advocacy and marking a significant step forward in the realm of Digital Capital and Digital Credit. Leadership...

Continue Reading